Related Experiment Video
Updated: May 13, 2025

10:41
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
7.2K
New Progressive Generalized Dystonia Phenotype in a Patient with NBEA-Related Neurodevelopmental Disease
Michał Schinwelski1, Magdalena Krygier2, Emilia J Sitek3,4
1Neurocentrum-Miwomed, Neurological Clinic, Gdansk, Poland.
Movement Disorders Clinical Practice
|April 16, 2025
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
323
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
323
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K

